The Effect of Neuraxial Morphine (Duramorph) on Pain Control
NCT03926559 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 125
Last updated 2020-07-08
Summary
With the rise of the opioid epidemic, it is important for physicians to be more mindful of the amount of narcotic prescriptions that are being written every day. In the early postpartum period, pain and fatigue are the most common problems reported by women. Untreated pain has negative consequences on the amount of opioid narcotics used, postpartum depression, and the potential development of persistent chronic pain. While pain can interfere with a woman's ability to adequately take care of her newborn, narcotic abuse can lead to excessive maternal drowsiness and increased infant mortality in the new breastfeeding mother. The most common sources of pain after a vaginal delivery include breast engorgement, uterine contractions and perineal lacerations. Perineal lacerations are immediate postpartum complications of the vaginal birth process, defined as injury that involves the bulbocavernosum muscle complex (second degree), and may involve the anal sphincter complex (third degree) or the anal epithelium (fourth degree). Prevention of chronic and severe postpartum pain, especially after a cesarean delivery has been extensively studied, however, much paucity in research exists for the management of postpartum pain from perineal tears. Compared to patients with first degree tears or intact perineum, women with severe perineal lacerations (second degree or greater) have increased analgesic requirement up to the fifth postpartum day. . Epidural morphine has been accepted by anesthesiologists as treatment for acute pain. In obstetrics, 2-3 mg of epidural morphine was found to be sufficient to provide post-episiotomy analgesia. Neuraxial morphine has been used for analgesic management after a cesarean section, especially to reduce the amount of oral pain medications used in the first 24 hours, but limited data exists on the use of neuraxial morphine after a severe perineal laceration repair in the setting of a vaginal delivery. Niv et al (1994) studied the effect of epidural morphine and monitored its timing of administration in post-epiostomy pain onset. They noted that if epidural morphine is administered before the onset of pain in an episiotomy repair it is much more effective than if given after the onset. This study hopes to take the prior 1994 study a step further and incorporates it's data to investigate whether neuraxial morphine given after a severe perineal laceration repair mitigates postpartum pain.
Conditions
- Perineal Tear
Interventions
- DRUG
-
Morphine.
Pregnant patients with a perineal tear postpartum receive 2mg of morphine through their epidural. This will be a one time dose immediately postpartum.
Sponsors & Collaborators
-
Augusta University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-04-01
- Primary Completion
- 2021-05-21
- Completion
- 2021-05-21
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Postpartum Pain Experience and Attitudes About Opioid Prescribing
NCT05202795 ·Status: COMPLETED
-
Intrapartum Epidural Fentanyl and Breast-feeding in the Immediate Postpartum Period: a Prospective Cohort Study
NCT01488149 ·Status: WITHDRAWN
-
The Influence of Breastfeeding on Cortical Activity During Procedures
NCT03272594 ·Status: COMPLETED ·Phase: PHASE3
-
Epidural Analgesia, Beta-Endorphin Concentrations in Colostrum, and Infant Neurobehavior as Breast-Feeding Predictors
NCT01191970 ·Status: WITHDRAWN
-
Impact of Breast Milk on Cortical Pain Response in Newborns
NCT05961904 ·Status: COMPLETED ·Phase: NA
-
Parent/Nurse Controlled Analgesia in the Neonatal Intensive Care Unit
NCT01823497 ·Status: COMPLETED ·Phase: NA
-
Methadone Pharmacokinetics and Cardiac Effects in Newborns
NCT00715988 ·Status: COMPLETED ·Phase: PHASE1
-
Maternal Involvement in Pain Management in NICU
NCT04883944 ·Status: COMPLETED ·Phase: NA
-
Pain Managment in Preterm Neonates
NCT07148882 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal
NCT01804075 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Additional Fentanyl to Epidural Bupivacaine for Post-Thoracotomy Pain in Neonates
NCT00286143 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome
NCT04298853 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Breast Feeding on Post-Cesarean and Post-Vaginal Delivery Pain
NCT01417260 ·Status: COMPLETED
-
Prevention of the Procedural Pain in the Newborn
NCT02109263 ·Status: COMPLETED ·Phase: NA
-
Olfactive Stimulation Interventions With Mothers' Milk on Preterm Pain Response
NCT04062513 ·Status: UNKNOWN ·Phase: NA
-
Neonatal Pain- and Distress Experiences and Later Pain Behavior of Former Preterm and Critically Ill Newborn Infants
NCT00926445 ·Status: UNKNOWN
-
Measuring Analgesic Interventions
NCT03794362 ·Status: RECRUITING
-
Assessing the Effects of Auricular Acupressure on Newborns With NAS
NCT03890562 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention
NCT02125201 ·Status: COMPLETED ·Phase: PHASE4
-
Postoperative Pain Control & Relief in Neonates
NCT03677830 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy of 50% Oral Dextrose As Pain Relief in Newborns Before Bladder Catheterization
NCT06635174 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Epidemiology of Pain in the Delivery Room
NCT03055039 ·Status: COMPLETED
-
Parent Nurse Controlled Analgesic in Pediatric Patients With Developmental Delay
NCT00743730 ·Status: COMPLETED ·Phase: NA
-
Improving Outcomes in Neonatal Abstinence Syndrome
NCT01958476 ·Status: COMPLETED ·Phase: PHASE3
-
Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain
NCT03396588 ·Status: COMPLETED ·Phase: PHASE3